At 12 months in a phase 1/2 trial, the Bimatoprost Drug Pad-IOL System improved IOP, vision and treatment burden in patients ...

At Vision Expo, the company behind the Heru Prime virtual reality headset for vision care pretesting showcased an upgrade ...

Some chronic diseases disproportionately affect Hispanic, Latino and African American people, and optometrists can better ...

Presentations among children with multiple food allergies vary by allergen combination, indicating distinct phenotypes, according to a poster presented at the American Academy of Allergy, Asthma & ...

The FDA approved the Tecnis PureSee IOL, an extended depth of focus IOL for cataract surgery, according to a press release ...

Exercise may reduce cancer-related cognitive impairment among people starting chemotherapy, according to results of a ...

Metabolites in tissue fluid offer important clues that could help predict infection risk among women who undergo breast ...

A 16-year-old female high school junior with a history of recurrent patellar instability presented with left knee pain following a patellar dislocation event.Two weeks earlier, she stepped onto a ...

Dyslipidemia is highly prevalent and the primary direct driver of atherosclerotic CVD. In the more than 7 years since the last American Heart Association/American College of Cardiology/Multisociety ...

Are time commitments related to cancer care toxic? Depends on who you ask.The term “time toxicity” has become cancer jargon ...

A new clinical delivery model offers resources to help health care providers, or HCPs, become more culturally competent and improve health outcomes for their Black patients, an expert said.BlackDoctor ...

The FDA approved secukimumab for children aged 12 years and older with moderate to severe hidradenitis suppurativa, Novartis announced in a press release.The approval makes secukinumab (Cosentyx) the ...